Thats true rae, but the point I was trying to make
is that the AVH share price is in the doldrums
now, because they have found the going hard
to penetrate the US market.
Don’t think the little Aussie battler OCC will find
it any easier. Some think when Covid is
diminished all will be well. IMO just because we
have great products, the opposition is not going
to just roll over. They will fight tooth and nail to
keep their share of the market and no doubt have
larger advertising budgets.
Further CelGro® nerve clinical trial data from all patients at 12 months, page-101
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |